Freely Accessible Scientific Literature. Higher Impact. Global Reach.
Haemophilia: the Bleeding Gene
April 17 marks World Haemophilia Day. Haemophilia, a hereditary lifelong genetic disorder, is a quite rare disorder one in about 10 000 persons is born with, much more common to occur in males; it impairs the body to control blood clotting when bleeding. The disorder can appear in two forms, Haemophilia A and Haemophilia B caused by different clotting factors but concerning the same symptom: longer bleeds. Haemophilia A is the most common form present in up to 85% of haemophilia patients.
Prolonged bleeding and re-bleeding are the diagnostic haemophilia symptoms. Patients suffering from this disorder have both cases of internal and external bleeding, spontaneously or on trauma and the bleedings mostly occur in the large joints, varying in frequency from a few times a week to just a few times a year.
Treatment for haemophilia involves replacing the missing clotting factor, either sourcing it from human blood plasma or using the so-called synthetic factor VIII. Once factor replacement therapy has been carried out, patients are encouraged to undertake physical therapy and rehabilitation in order to prevent joint deformation. In case haemophiliacs don't get treatment, consequences could involve death or severe anaemia, severe deformities of joints, flexion/extension deformities, weakness of legs, shortening of leg leading to permanent damages. There is yet no cure for this particular blood condition.
• Worldwide, the % of the population affected with haemophilia is estimated at 1 x 10 000 (2005)
• The total number of people diagnosed with haemophilia A and B in the EU in 2004 was 33,145
• Currently, the number of people with haemophilia in the United States is estimated to be about 20,000, based on expected births and deaths since 1994
• In about two thirds of cases, there is a family history of hemophilia
The WFH launched the "Close the gap" campaign to raise global awareness on this rare disease and help making treatments available at a global level. To find out how to embrace the cause and help spread awareness please click here.
For further information about haemophilia please refer to the InTech's list of publications on the subject below; all InTech's publications are free to read, share and download.
Haemophilia, edited by Angelika Batorova, InTech, Mar. 2012
Targets in Gene Therapy, edited by Yongping You, InTech, Aug. 2011
Ana Nodilo, email@example.com